230 related articles for article (PubMed ID: 2109678)
1. Aldose reductase inhibitors in the treatment of diabetic neuropathy. A review of the rationale and clinical evidence.
Masson EA; Boulton AJ
Drugs; 1990 Feb; 39(2):190-202. PubMed ID: 2109678
[TBL] [Abstract][Full Text] [Related]
2. Aldose reductase inhibition for diabetic neuropathy.
Lancet; 1983 Oct; 2(8356):969. PubMed ID: 6138528
[No Abstract] [Full Text] [Related]
3. Aldose reductase inhibitors and late complications of diabetes.
Benfield P
Drugs; 1986; 32 Suppl 2():43-55. PubMed ID: 3098544
[TBL] [Abstract][Full Text] [Related]
4. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.
Sima AA; Bril V; Nathaniel V; McEwen TA; Brown MB; Lattimer SA; Greene DA
N Engl J Med; 1988 Sep; 319(9):548-55. PubMed ID: 3136331
[TBL] [Abstract][Full Text] [Related]
5. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
Christensen JE; Larsen AB; Gregersen G
Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975
[No Abstract] [Full Text] [Related]
6. The pathology of diabetic neuropathy and the effects of aldose reductase inhibitors.
Gillon KR; King RH; Thomas PK
Clin Endocrinol Metab; 1986 Nov; 15(4):837-53. PubMed ID: 3096616
[No Abstract] [Full Text] [Related]
7. Can aldose reductase inhibition ameliorate diabetic neuropathy?
González ER
JAMA; 1981 Sep; 246(11):1169-70. PubMed ID: 6790734
[No Abstract] [Full Text] [Related]
8. The effect of an aldose reductase inhibitor (Sorbinil) on diabetic neuropathy and neural function of the retina: a double-blind study.
Christensen JE; Varnek L; Gregersen G
Acta Neurol Scand; 1985 Feb; 71(2):164-7. PubMed ID: 3920861
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of aldose reductase in human diabetic neuropathy.
Jaspan J
Drugs; 1986; 32 Suppl 2():23-9. PubMed ID: 2431859
[TBL] [Abstract][Full Text] [Related]
10. Aldose reductase inhibition in the treatment of diabetic neuropathy: where are we in 2004?
Gabbay KH
Curr Diab Rep; 2004 Dec; 4(6):405-8. PubMed ID: 15539002
[TBL] [Abstract][Full Text] [Related]
11. Potential use of aldose reductase inhibitors to prevent diabetic complications.
Zenon GJ; Abobo CV; Carter BL; Ball DW
Clin Pharm; 1990 Jun; 9(6):446-57. PubMed ID: 2114249
[TBL] [Abstract][Full Text] [Related]
12. Aldose reductase inhibitors in clinical practice. Preliminary studies on diabetic neuropathy and retinopathy.
Pitts NE; Gundersen K; Mehta DJ; Vreeland F; Shaw GL; Peterson MJ; Collier J
Drugs; 1986; 32 Suppl 2():30-5. PubMed ID: 3098543
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial of an aldose reductase inhibitor in diabetic neuropathy.
Handelsman DJ; Turtle JR
Diabetes; 1981 Jun; 30(6):459-64. PubMed ID: 6785131
[TBL] [Abstract][Full Text] [Related]
14. Current progress in clinical trials of aldose reductase inhibitors in Japan.
Hotta N; Kakuta H; Ando F; Sakamoto N
Exp Eye Res; 1990 Jun; 50(6):625-8. PubMed ID: 2115451
[TBL] [Abstract][Full Text] [Related]
15. Effect of an aldose reductase inhibitor on diabetic peripheral neuropathy. Preliminary report.
Culebras A; Alió J; Herrera JL; López-Fraile MI
Arch Neurol; 1981 Feb; 38(2):133-4. PubMed ID: 6781454
[No Abstract] [Full Text] [Related]
16. Aldose reductase inhibitors for the treatment of diabetic polyneuropathy.
Chalk C; Benstead TJ; Moore F
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD004572. PubMed ID: 17943821
[TBL] [Abstract][Full Text] [Related]
17. [Aldose reductase inhibitors in diabetic neuropathy].
Erkelens DW; Bravenboer B
Ned Tijdschr Geneeskd; 1990 Apr; 134(15):775-6. PubMed ID: 2110629
[No Abstract] [Full Text] [Related]
18. WITHDRAWN: Aldose reductase inhibitors for the prevention and treatment of diabetic peripheral neuropathy.
Airey M; Bennett C; Nicolucci A; Williams R
Cochrane Database Syst Rev; 1996 Apr; (1):CD002182. PubMed ID: 17636697
[TBL] [Abstract][Full Text] [Related]
19. Clinical potential of aldose reductase inhibitors in diabetic neuropathy.
Hamada Y; Nakamura J
Treat Endocrinol; 2004; 3(4):245-55. PubMed ID: 16026107
[TBL] [Abstract][Full Text] [Related]
20. Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.
Fagius J; Jameson S
J Neurol Neurosurg Psychiatry; 1981 Nov; 44(11):991-1001. PubMed ID: 6801211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
